Related Experiment Videos
Treating hyperlipidemia, Part III: Drug therapy
Geriatrics
|August 1, 1987
Summary
Elderly patients with high cholesterol or triglycerides have medication options, but side effects may require lower doses. Nicotinic acid and gemfibrozil treat high triglycerides, while other drugs reduce LDL cholesterol.
Area of Science:
- Geriatric Medicine
- Cardiovascular Pharmacology
- Lipid Metabolism
Background:
- Elderly patients often face cardiovascular disease risks due to lipid abnormalities.
- Managing dyslipidemia in older adults requires careful consideration of medication side effects and appropriate dosing.
Purpose of the Study:
- To review available medications for lipid abnormalities in elderly patients.
- To highlight specific drug choices for managing hypertriglyceridemia and high LDL cholesterol in this population.
Main Methods:
- Literature review of pharmacological agents for lipid management.
- Analysis of drug efficacy and safety profiles in elderly populations.
- Categorization of treatments based on lipid targets (triglycerides, LDL cholesterol).
Main Results:
- Nicotinic acid (Niacin) and gemfibrozil (Lopid) are options for severe triglyceride elevations.
- Bile acid-binding resins, nicotinic acid, HMG CoA reductase inhibitors, probucol (Lorelco), and neomycin can reduce LDL cholesterol.
Conclusions:
- Multiple pharmacologic strategies exist for lipid management in at-risk elderly individuals.
- Individualized treatment plans are essential, considering potential dose adjustments due to age-related factors and side effects.